Chinese expert consensus on weight management in obesefemale patients with stress urinary incontinence(2020)[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 1-5. DOI: 10.7619/jcmp.202002001
Citation: Chinese expert consensus on weight management in obesefemale patients with stress urinary incontinence(2020)[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 1-5. DOI: 10.7619/jcmp.202002001

Chinese expert consensus on weight management in obesefemale patients with stress urinary incontinence(2020)

More Information
  • Received Date: October 19, 2019
  • Available Online: August 26, 2020
  • Published Date: August 26, 2020
  • Gordon B, Shorter B, Isoldi K K, et al. Obesity with comorbid stress urinary incontinence in women: a narrative review to inform dietetics practice[J]. J Acad Nutr Diet, 2017, 117(6): 889-907.
    Townsend M K, Danforth K N, Rosner B, et al. Body mass index, weight gain, and incident urinary incontinence in middle-aged women[J]. Obstet Gynecol, 2007, 110(2 Pt 1): 346-353.
    Abrams P, Andersson K E, Brubaker L. Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecalincontinence[M]. Abrams P, Cardozo L, Khoury S, et al. Incontinence. 3rd ed. Paris: Health Publications Ltd, 2005: 1589-1630.
    National Institute for Health and Clinical Excellence. Urinary incontinence in women, guidance[M]. London: NICE, 2015: 21-28.
    中华医学会妇产科学分会妇科盆底学组. 女性压力性尿失禁诊断和治疗指南(2017)[J]. 中华妇产科杂志, 2017, 52(5): 289-293.
    Zhu L, Lang J H, Liu C Y, et al. The epidemiological study of women with urinary incontinence and risk factors for stress urinary incontinence in China[J]. Menopause, 2009, 16(4): 831-836.
    Dallosso H M, McGrother C W, Matthews R J, et al. The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women[J]. BJU Int, 2003, 92(1): 69-77.
    Fuselier A, Hanberry J, Margaret Lovin J, et al. Obesity and stress urinary incontinence: impact on pathophysiology and treatment[J]. Curr Urol Rep, 2018, 19(1): 10-17.
    Wing R R, Creasman J M, West D S, et al. Improving urinary incontinence in overweight and obese women through modest weight loss[J]. Obstet Gynecol, 2010, 116(2 Pt 1): 284-292.
    Subak L L, Wing R, West D S, et al. Weight loss to treat urinary incontinence in overweight and obese women[J]. N Engl J Med, 2009, 360(5): 481-490.
    Brown J S, Wing R, Barrett-Connor E, et al. Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program[J]. Diabetes Care, 2006, 29(2): 385-390.
    Phelan S, Kanaya A M, Subak L L, et al. Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial[J]. J Urol, 2012, 187(3): 939-944.
    Look AHEAD Research Group, Wadden T A, West D S, et al. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it[J]. Obesity(Silver Spring), 2006, 14(5): 737-752.
    Gleason J L, Richter H E, Redden D T, et al. Caffeine and urinary incontinence in US women[J]. Int Urogynecol J, 2013, 24(2): 295-302.
    Wyman J F, Burgio K L, Newman D K. Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence[J]. Int J Clin Pract, 2009, 63(8): 1177-1191.
    Institute of Medicine. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate[M]. Washington D. C.: National Academies Press, 2005: 1-10.
    Ryan D H, Espeland M A, Foster G D, et al. Look AHEAD(Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes[J]. Control Clin Trials, 2003, 24(5): 610-628.
    江波, 白文佩, 郁琦, 等. 生酮饮食干预多囊卵巢综合征中国专家共识(2018年版)[J]. 实用临床医药杂志, 2019, 23(1): 1-4.
    白栎然, 李健, 牛犁天, 等. 生酮饮食干预多囊卵巢综合征单中心临床研究的初期报告[J]. 实用临床医药杂志, 2019, 23(7): 2-5.
    Choi K M. Sarcopenia and sarcopenic obesity[J]. Korean J Intern Med, 2016, 31(6): 1054-1060.
    Marty E, Liu Y, Samuel A, et al. A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease[J]. Bone, 2017, 105: 276-286.
  • Cited by

    Periodical cited type(14)

    1. 张华朋,章赛玉,陈华永. 七氟烷对冠心病颅脑手术患者行控制性降血压的脑保护效果. 中国当代医药. 2021(09): 117-120 .
    2. 杜力侠,沈如刚. 静吸复合麻醉与全凭静脉麻醉在急性创伤性颅脑损伤患者治疗中的效果分析. 系统医学. 2021(19): 4-7 .
    3. 张娇娇,薛志强,刘丽霞. 异丙酚联合地氟烷麻醉对颅脑损伤患者的脑保护作用研究. 湖南师范大学学报(医学版). 2020(01): 142-145 .
    4. 郝维强,魏宏姗. 重型颅脑损伤丙泊酚麻醉临床分析. 中国继续医学教育. 2020(06): 70-73 .
    5. 汪金娇,李海中,刘彦锋. 丙泊酚全身麻醉对颅脑外伤急诊手术患者神经损伤程度及氧化应激影响. 社区医学杂志. 2020(11): 792-795 .
    6. 张志伟,孙荣青. 右美托咪定联合瑞芬太尼在重型颅脑损伤术后镇痛镇静效果. 内蒙古医学杂志. 2020(08): 959-960 .
    7. 李军根,陆士奇,肖接承,丁礼. 全凭静脉麻醉与静吸复合麻醉对重症颅脑创伤患者血流动力学及IL-6、ADR、NADR水平的影响. 现代医学与健康研究电子杂志. 2020(15): 72-74 .
    8. 王安平,岳新霞,海力茜·陶尔大洪,陈新,罗庆元. 丙泊酚对重型颅脑损伤手术患者血流动力学、术后镇痛镇静效果及血清hs-CRP、PCT、IL-22表达的影响. 解放军医药杂志. 2019(02): 107-112 .
    9. 潘明,贾衍杰. 丙泊酚静脉麻醉在急性重型颅脑损伤手术患者中的应用效果. 中国当代医药. 2019(02): 183-185 .
    10. 王仕斌,王雪婷,薛荣亮,陈蓉,路丕周,刘世明. 异丙酚联合地氟烷麻醉对颅脑损伤患者脑保护及脑供氧平衡的影响. 现代生物医学进展. 2019(24): 4793-4796 .
    11. 陈艳霞. 瑞芬太尼复合丙泊酚对重型颅脑损伤患者脑氧代谢及炎症因子的影响. 临床研究. 2018(11): 36-38 .
    12. 吴悠扬,周春丽,王勇. 丙泊酚复合瑞芬太尼靶控输注联合灯盏细辛注射液对脑胶质瘤切除术患者脑保护及苏醒质量的影响. 现代中西医结合杂志. 2018(29): 3290-3293 .
    13. 田佩松. 颅脑损伤手术中全凭静脉麻醉与静吸复合麻醉的应用效果对比. 实用医技杂志. 2018(12): 1385-1387 .
    14. 许镇. 右美托咪定与丙泊酚对重症颅脑损伤患者脑代谢及预后的影响比较. 中外医学研究. 2018(31): 148-149 .

    Other cited types(0)

Catalog

    Article views (331) PDF downloads (49) Cited by(14)
    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return